Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/9/26 17:46 | 9/4/26 | PCVX | Health | BioPrd | Biological Products, (No Diag | Wassil Jim | CA | O | EVP,Chie | 7 | S.dm | -651 | 41.44 | 0 | -16 | 158 | D | |||||||||||||||
8/5/26 19:01 | 8/5/26 | PCVX | Health | BioPrd | Biological Products, (No Diag | Dhaliwal Harpreet S. | CA | O | Chief Te | 2 | M.d | 1,356 | 39.90 | 0 | 34 | 80 | 77 | D | ||||||||||||||
8/5/26 19:01 | 8/5/26 | PCVX | Health | BioPrd | Biological Products, (No Diag | Dhaliwal Harpreet S. | CA | O | Chief Te | 2 | S.d | -1,356 | 39.90 | 0 | -34 | 77 | D | |||||||||||||||
8/5/26 16:58 | 8/3/26 | PCVX | Health | BioPrd | Biological Products, (No Diag | Guggenhime Andrew | CA | O | P,CFO | 6 | M.d | 1,802 | 30.04 | 0 | 60 | 56 | 167 | D | ||||||||||||||
8/5/26 16:58 | 8/3/26 | PCVX | Health | BioPrd | Biological Products, (No Diag | Guggenhime Andrew | CA | O | P,CFO | 6 | S.d | -1,802 | 30.04 | 0 | -60 | 167 | D | |||||||||||||||
7/28/26 16:10 | 7/27/26 | PCVX | Health | BioPrd | Biological Products, (No Diag | Pickering Grant | CA | DO | CEO | 5 | M.d | 3,668 | 44.03 | 0 | 83 | 16 | 610 | M | ||||||||||||||
7/28/26 16:10 | 7/27/26 | PCVX | Health | BioPrd | Biological Products, (No Diag | Pickering Grant | CA | DO | CEO | 5 | S.d | -3,668 | 44.03 | 0 | -83 | 610 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |